# Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial)

> **NCT06125925** · NA · RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 436 (estimated)

## Conditions studied

- Atrial Fibrillation
- HFpEF - Heart Failure With Preserved Ejection Fraction

## Interventions

- **PROCEDURE:** Radiofrequency catheter ablation (RFCA)
- **DRUG:** Medical Therapy

## Key facts

- **NCT ID:** NCT06125925
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-06
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 436 (ESTIMATED)
- **Last updated:** 2023-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06125925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06125925, "Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06125925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*